Abstract:Background Hepatocellular carcinoma (HOC) often occurs in association with liver cirrhosis. A stepwise carcinogenesis for HOC has been proposed. The purpose of this study was to observe the enhancement pattern of hepatocellular nodules in cirrhotic patients using contrast-enhanced ultrasound (CEUS) and to correlate patterns of enhancement at CEUS with the diagnosis of hepatocellular nodules using pathologic correlation as the gold standard. Methods Ninety-three cirrhotic patients with indeterminate hepatocellular nodules at ultrasound, underwent biopsy of each indeterminate nodule. Patients with nodules found to have pathologic diagnoses of regenerative nodules (RNs), dysplastic nodules (DNs), or DNs with focus of HOC (DN-HCC), were enrolled in this study. Enhancement patterns of all nodules were examined throughout the various vascular phases of CEUS and classified into five enhancement patterns: type I, isoenhancement to hepatic parenchyma at all phases; type II, hypoenhancement in the arterial phase, and isoenhancement in the portal venous phase and late phase; type III, iso-to-hypoenhancement in arterial and portal venous phase, and hypoenhancement in the late phase (washout); type IV, slight hyperenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout); and type V, partial hyperenhancement in the arterial phase and hypoenhancement in the late phase; and another partial iso-to-hypoenhancement in the arterial and portal venous phase and hypoenhancement in the late phase (washout). The correlation between the contrast enhancement patterns and the pathological diagnoses was analyzed by the chi-squared test. Results Totally 132 lesions were examined with CEUS in 93 patients. Pathologic diagnoses included 45 DN, 68 RN, and 19 DN-HCC. The enhancement patterns observed were as follows: type 1,49 (37.1%); type II, 27 (20.5%); type III, 28 (21.2%); type IV, 9 (6.8%); type V, 19 (14.4%). Nodules with type I enhancement showed dysplasia in 5 (10.2%) cases; nodules with type II were dysplastic in 11(40.7%) of cases; nodules with type Ill enhancement pattern were dysplastic in 22 (78.6%), and those with type IV enhancement contained dysplasia in 7 (77.8%) of cases. Type V enhancement corresponded to DN-HCC in 19(100%) of cases. CEUS enhancement pattern was correlated with likelihood of dysplasia at pathologic analysis (Trend chi-square test, P <0.001). Pathological diagnosis was HOC in the enhanced area and hepatocyte dysplasia in the un-enhanced area in the 19 DN-HCC. Conclusion Pattern of enhancement at CEUS correlates with the pathologic diagnosis of hepatocellular nodules in liver cirrhosis, and may be helpful in predicting the progress from RN to HOC nodules. Chin Med J 2012;125(17):3104-3109

Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Evaluation of Contrast-Enhanced Ultrasound for Diagnosis of Dysplastic Nodules with a Focus of Hepatocellular Carcinoma in Liver Cirrhosis Patients

Response to Letter to the Editor Regarding the Article "Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement" by Zhou and Collaborators

Assessment of Liver Metastasis in Patients with Advanced Gastric Cancer Using Contrast-Enhanced Ultrasonography

Evaluation of contrast-enhanced ultrasound for the diagnosis of dysplastic nodule in liver cirrhosis

Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis

Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study

Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography.

Diagnostic Value of Contrast‐enhanced Ultrasound for Dysplastic Nodule with a Focus of Hepatocellular Carcinoma

Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.

The Role of Contrast-Enhanced Ultrasound on the Diagnosis of Small Hepatocellular Carcinoma (≤3cm) in Patients with Cirrhosis

Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.

Contrast-enhanced Ultrasound Features of Hepatocellular Carcinoma Not Detected During the Screening Procedure

Clinical application of contrast-enhanced ultrasonography for malignant hepatic lesions undetected on conventional ultrasound

Comparison Of Contrast-Enhanced Ultrasound And Contrast-Enhanced Helical Ct In The Diagnosis Of High Echo-Level Small Focal Liver Lesions

Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis

[Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].

Contrast-enhanced ultrasound versus contrast-enhanced MRI for diagnosis of well-differentiated hepatocellular carcinoma and precancerous lesions

[Early Diagnosis of Small Hepatocellular Carcinoma by New Contrast-Enhanced Ultrasound Technique].